Malignant Peripheral Nerve Sheath Tumor Latest Advances

The Cell Surface Proteome of Malignant Peripheral Nerve Sheath Tumors Reveals Therapeutic Targets.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Malignant Peripheral Nerve Sheath Tumor of the Pancreas: A Case Report and Updated Review of Related Literature.

Journal: Acta medica Philippina

Published: April 10, 2026

PRMT5 is Frequently Upregulated and a Potential Therapeutic Target in MTAP-deficient Malignant Peripheral Nerve Sheath Tumors.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Prognostic factors in neurofibromatosis type 1 (NF1)-associated malignant peripheral nerve sheath tumors: Clinical implications beyond NF1 status.

Journal: Cancer

Published: April 09, 2026

Driving proteomic imbalance in malignancy provokes proteomic catastrophe and confers tumor suppression.

Journal: bioRxiv : the preprint server for biology

Published: March 16, 2026

Schwannoma: a spectrum from benign to malignant.

Journal: Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie

Published: March 05, 2026

Intratumoral plasma cells mediate CD8+ T cell infiltration and successful immune checkpoint blockade therapy in de novo MPNSTs.

Journal: bioRxiv : the preprint server for biology

Published: February 27, 2026

Reply to "Prognostic factors in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors: Clinical implications beyond NF1 status".

Journal: Cancer

Published: February 26, 2026

Refractory Cancer Pain in a Pediatric Patient With Advanced Malignant Peripheral Nerve Sheath Tumor: A Total Pain-Oriented Palliative Care Approach.

Journal: Cureus

Published: February 06, 2026

Defining Prognostic Markers and Clinical Outcomes in Epithelioid Malignant Peripheral Nerve Sheath Tumor.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: January 26, 2026

Near-Bloodless Resection of a Giant Hypervascular NF1-Associated Malignant Peripheral Nerve Sheath Tumor Using Dual-Modality Preoperative Embolization.

Journal: International journal of dermatology

Published: January 12, 2026

Heterologous Rhabdomyoblastic Differentiation in Dedifferentiated Liposarcoma Is Significantly Associated With Loss of H3K27 Trimethylation.

Journal: Pathology international

Published: January 07, 2026

Malignant Peripheral Nerve Sheath Tumor Latest Advances

Find the Latest Research About Malignant Peripheral Nerve Sheath Tumor

The Cell Surface Proteome of Malignant Peripheral Nerve Sheath Tumors Reveals Therapeutic Targets.

The Cell Surface Proteome of Malignant Peripheral Nerve Sheath Tumors Reveals Therapeutic Targets.

Malignant Peripheral Nerve Sheath Tumor of the Pancreas: A Case Report and Updated Review of Related Literature.

Malignant Peripheral Nerve Sheath Tumor of the Pancreas: A Case Report and Updated Review of Related Literature.

PRMT5 is Frequently Upregulated and a Potential Therapeutic Target in MTAP-deficient Malignant Peripheral Nerve Sheath Tumors.

PRMT5 is Frequently Upregulated and a Potential Therapeutic Target in MTAP-deficient Malignant Peripheral Nerve Sheath Tumors.

Prognostic factors in neurofibromatosis type 1 (NF1)-associated malignant peripheral nerve sheath tumors: Clinical implications beyond NF1 status.

Prognostic factors in neurofibromatosis type 1 (NF1)-associated malignant peripheral nerve sheath tumors: Clinical implications beyond NF1 status.

Driving proteomic imbalance in malignancy provokes proteomic catastrophe and confers tumor suppression.

Driving proteomic imbalance in malignancy provokes proteomic catastrophe and confers tumor suppression.

Schwannoma: a spectrum from benign to malignant.

Schwannoma: a spectrum from benign to malignant.

Intratumoral plasma cells mediate CD8+ T cell infiltration and successful immune checkpoint blockade therapy in de novo MPNSTs.

Intratumoral plasma cells mediate CD8+ T cell infiltration and successful immune checkpoint blockade therapy in de novo MPNSTs.

Reply to "Prognostic factors in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors: Clinical implications beyond NF1 status".

Reply to "Prognostic factors in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors: Clinical implications beyond NF1 status".

Refractory Cancer Pain in a Pediatric Patient With Advanced Malignant Peripheral Nerve Sheath Tumor: A Total Pain-Oriented Palliative Care Approach.

Refractory Cancer Pain in a Pediatric Patient With Advanced Malignant Peripheral Nerve Sheath Tumor: A Total Pain-Oriented Palliative Care Approach.

Defining Prognostic Markers and Clinical Outcomes in Epithelioid Malignant Peripheral Nerve Sheath Tumor.

Defining Prognostic Markers and Clinical Outcomes in Epithelioid Malignant Peripheral Nerve Sheath Tumor.

Near-Bloodless Resection of a Giant Hypervascular NF1-Associated Malignant Peripheral Nerve Sheath Tumor Using Dual-Modality Preoperative Embolization.

Near-Bloodless Resection of a Giant Hypervascular NF1-Associated Malignant Peripheral Nerve Sheath Tumor Using Dual-Modality Preoperative Embolization.

Heterologous Rhabdomyoblastic Differentiation in Dedifferentiated Liposarcoma Is Significantly Associated With Loss of H3K27 Trimethylation.

Heterologous Rhabdomyoblastic Differentiation in Dedifferentiated Liposarcoma Is Significantly Associated With Loss of H3K27 Trimethylation.